Home Featured Page 190

Featured

Latest

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M

Wesana Health Provides Strategic and Operational Updates

Field Trip Receives Notice of Allowance for US Patent Application Covering...

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel...

Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted...

PT283 – Greg McKee – Nociplastic Pain and Psychedelics

Psychedelic Research and Clinical Trials in 2021

Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development...

Stephen Hurst Resigns from MindMed Board of Directors

Mydecine Innovations Group Engages JBN Partners, LLC for Marketing Services

1...189190191...301 Page 190 of 301

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M

Wesana Health Provides Strategic and Operational Updates

Field Trip Receives Notice of Allowance for US Patent Application Covering...

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel...

Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted...

PT283 – Greg McKee – Nociplastic Pain and Psychedelics

Psychedelic Research and Clinical Trials in 2021

Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development...

Stephen Hurst Resigns from MindMed Board of Directors

Mydecine Innovations Group Engages JBN Partners, LLC for Marketing Services

EDITOR PICKS

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY